TAK - Pfizer succeeds in Phase 3 trial for Adcetris in new lymphoma condition
2024-03-12 07:45:49 ET
More on Pfizer
- Pfizer: A Strong Buy Trading Below A 10 P/E Ratio
- Pfizer Inc. (PFE) TD Cowen 44th Annual Health Care Conference
- 6%-Yielding Pfizer Is An Ultra-Deep-Value Gem In An Expensive Market
- Biden to push for expanding Medicare drug pricing program
- Pfizer wins FDA nod for antibody drug conjugate Besponsa in children